Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

S&P Biotech SPDR (XBI)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fund Basics

See More
  • Fund Family State Street Global Advisors
  • Assets Under Management 5,219,760,000
  • Market Capitalization, $K 5,219,760
  • Shares Outstanding, K 54,600
  • 36-Month Beta 2.08
  • Price/Book N/A
  • Price/Earnings ttm 19.41
  • Annual Dividend & Yield 0.15 (0.16%)
  • Most Recent Dividend 0.058 on 06/15/18
  • Sectors:

    ETFs - Biotech

Price Performance

See More
Period Period Low Period High Performance
1-Month
93.41 +4.01%
on 08/21/18
100.70 -3.52%
on 08/30/18
+3.86 (+4.14%)
since 08/20/18
3-Month
91.91 +5.71%
on 06/28/18
101.55 -4.32%
on 06/21/18
-3.99 (-3.94%)
since 06/20/18
52-Week
78.46 +23.83%
on 11/15/17
101.55 -4.32%
on 06/21/18
+11.99 (+14.08%)
since 09/20/17

Most Recent Stories

More News
4 Sector ETFs That Crushed S&P 500 in Longest Bull Market

These sector ETFs outperformed the S&P 500 in the longest-ever bull market.

FDN : 141.91 (+0.87%)
XLY : 117.79 (+0.68%)
VCR : 181.38 (+0.55%)
QTEC : 79.50 (+1.26%)
FXH : 83.09 (+0.70%)
PJP : 73.41 (+1.16%)
FBT : 154.40 (+2.18%)
SOXX : 188.80 (+1.21%)
SPY : 293.58 (+0.81%)
XBI : 97.16 (+1.66%)
4 Sector ETFs That Crushed S&P 500 in Longest Bull Market

These sector ETFs outperformed the S&P 500 in the longest-ever bull market.

FDN : 141.91 (+0.87%)
XLY : 117.79 (+0.68%)
VCR : 181.38 (+0.55%)
QTEC : 79.50 (+1.26%)
FXH : 83.09 (+0.70%)
PJP : 73.41 (+1.16%)
FBT : 154.40 (+2.18%)
SOXX : 188.80 (+1.21%)
SPY : 293.58 (+0.81%)
XBI : 97.16 (+1.66%)
What Investors Need to Know about Biotech ETFs

Smaller biotech stocks are outperforming this year; learn more about biotech ETFs best positioned to benefit

IBB : 119.29 (+1.39%)
FBT : 154.40 (+2.18%)
XBI : 97.16 (+1.66%)
What Investors Need to Know about Biotech ETFs

Smaller biotech stocks are outperforming this year; learn more about biotech ETFs best positioned to benefit

IBB : 119.29 (+1.39%)
FBT : 154.40 (+2.18%)
XBI : 97.16 (+1.66%)
Sarepta Pharma Pushes Two Biotech ETFs to New Highs

The encouraging early trial results for a gene therapy for Duchenne muscular dystrophy pushed Sarepta Therapeutics and few biotech ETFs to new highs.

BBP : 44.68 (+1.61%)
SLDB : 51.70 (+5.38%)
BBC : 35.08 (+2.84%)
SBIO : 37.92 (+2.13%)
SRPT : 152.83 (+0.58%)
IBB : 119.29 (+1.39%)
VRTX : 180.52 (+2.22%)
ALNY : 95.21 (+0.41%)
XBI : 97.16 (+1.66%)
ALXN : 124.61 (+2.16%)
BIIB : 341.24 (+0.69%)
Sarepta Pharma Pushes Two Biotech ETFs to New Highs

The encouraging early trial results for a gene therapy for Duchenne muscular dystrophy pushed Sarepta Therapeutics and few biotech ETFs to new highs.

BBP : 44.68 (+1.61%)
SLDB : 51.70 (+5.38%)
BBC : 35.08 (+2.84%)
SBIO : 37.92 (+2.13%)
SRPT : 152.83 (+0.58%)
IBB : 119.29 (+1.39%)
VRTX : 180.52 (+2.22%)
ALNY : 95.21 (+0.41%)
XBI : 97.16 (+1.66%)
ALXN : 124.61 (+2.16%)
BIIB : 341.24 (+0.69%)
Should You Invest in the PowerShares Dynamic Biotechnology & Genome Portfolio (PBE)?

Sector ETF report for PBE

PBE : 58.47 (+1.46%)
ILMN : 356.32 (+1.70%)
IBB : 119.29 (+1.39%)
QGEN : 38.30 (+0.42%)
XBI : 97.16 (+1.66%)
BIIB : 341.24 (+0.69%)
Why These Small Cap Biotech ETFs are Soaring

These biotech ETFs have surged this year thanks mainly to tax reform, rising M&A and positive regulatory backdrop.

BBC : 35.08 (+2.84%)
CNCR : 24.96 (+1.59%)
IBB : 119.29 (+1.39%)
PSCH : 141.61 (+0.90%)
XBI : 97.16 (+1.66%)
Why These Small Cap Biotech ETFs are Soaring

These biotech ETFs have surged this year thanks mainly to tax reform, rising M&A and positive regulatory backdrop.

BBC : 35.08 (+2.84%)
CNCR : 24.96 (+1.59%)
IBB : 119.29 (+1.39%)
PSCH : 141.61 (+0.90%)
XBI : 97.16 (+1.66%)
Strong Week Despite Weak Finish

Strong Week Despite Weak Finish

YY : 74.20 (+3.07%)
CPA : 80.71 (+0.79%)
INTT : 8.10 (-1.22%)
SNE : 59.10 (+0.17%)
XBI : 97.16 (+1.66%)
AMZN : 1,944.30 (+0.93%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 16% Buy with a Strengthening short term outlook on maintaining the current direction.

Longer term, the trend strength is Minimum. Long term indicators fully support a continuation of the trend.

See More Share

Trade XBI with:

Fund Summary

The SPDR SP Biotech ETF seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the SP Biotechnology Select Industry Index.

See More

Key Turning Points

2nd Resistance Point 98.03
1st Resistance Point 97.60
Last Price 97.16
1st Support Level 96.31
2nd Support Level 95.45

See More

52-Week High 101.55
Last Price 97.16
Fibonacci 61.8% 92.73
Fibonacci 50% 90.01
Fibonacci 38.2% 87.28
52-Week Low 78.46

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar